Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for the treatment of bipolar disorders.

Trial Profile

Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for the treatment of bipolar disorders.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Oct 2012

At a glance

  • Drugs Escitalopram (Primary) ; Carbamazepine; Gabapentin; Lamotrigine; Levetiracetam; Lithium; Oxcarbazepine; Valproic acid
  • Indications Anxiety; Bipolar disorders; Depressive disorders; Major depressive disorder; Obsessive-compulsive disorders; Panic disorder
  • Focus Pharmacodynamics; Pharmacogenomic; Pharmacokinetics
  • Most Recent Events

    • 29 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top